SEMINAR 1. Title : Discovery of Protein-Protein Interaction Modulators Using Affinity-Based High-Throughput Screening 2. Speaker : Hyun-Suk Lim (포항공대 (POSTECH))

Slides:



Advertisements
Similar presentations
Postgraduate Course in Pharmaceutical Medicine A warm welcome to all participants.
Advertisements

Professor Robin Leatherbarrow Head of Biological Chemistry Department of Chemistry.
Integrative Organs Systems Scientists and Drug Discovery: The Link Between Big Pharma and Academia Glenn A. Reinhart, Ph.D. Senior Group Leader Integrative.
Jeffery Loo NLM Associate Fellow ’03 – ’05 chemicalinformaticsforlibraries.
Discovery of new medicines through new models of collaboration Simon Ward Professor of Medicinal Chemistry & Director of Translational Drug Discovery Group.
Department of Chemistry Seminar Announcement Date/Time/VenueTitle/Speaker 21 Feb (Mon) 4pm – S8 Level 3 Executive Classroom Natural products and.
The Nobel Prize in Physiology or Medicine 1994 "for their discovery of G-proteins and the role of these proteins in signal transduction in cells"
Intellectual Property Rights and Pharmaceutical Industry
Pathway: a collection of genes, proteins, and /or small molecules that modulate a cellular process or disease state Growing demand in biological sciences.
Department of Chemistry Seminar Announcement Date/Time/VenueTitle/Speaker 12 Jan (Wed) 11am – S8 Level 3 Executive Classroom PET in Neuroscience.
Trend in diagnostic biochip development Eiichiro Ichiishi, M.D., Ph.D. Department of Internal Medicine International University of Health and Welfare Hospital.
Today’s Drug Discovery Process “How Do We Discover Drugs” Dr. Vincent P. Gullo Drew University.
A model collaboration using the Pool Susanne Hollinger, Ph.D., J.D. Chief Intellectual Property Officer Emory University.
26th April 2016, BioTrinity - London
Analysis of Global New Molecular Entities 2012 The beginning of a new wave? Analysis of Global New Molecular Entities 2012 The beginning of a new wave?
Molecular Modeling in Drug Discovery: an Overview
Medicinal Chemistry Lecture – I Introduction and Course Overview Joseph O. Oweta B. Pharm (MUST)
Interviewing for the Pharmaceutical Industry: what does it involve and how to succeed? David P Brooks.
Page 1 NMR Services —by Creative Biostructure. Page 2 NMR spectroscopy is a key analytical technique for structure elucidation of a wide range of materials.
Page 1 Computer-aided Drug Design —Profacgen. Page 2 The most fundamental goal in the drug design process is to determine whether a given compound will.
Special Seminar Series
Dr. George Geromichalos, Ph.D.
Sungkyunkwan University, School of Medicine.
SEMINAR 1. Title : Organic/2D material based devices for flexible electronics 2. Speaker : Tae Hoon Lee ( Kwangwoon University ) 3. Time : 16:00.
SEMINAR 1. Title : Present and Future of Korean Manufacturing Industry
SEMINAR 1. Title : Electroactive Polymers for Innovative Energy Devices 2. Speaker : Young-Gi Kim, Ph.D (Delaware State University ) 3. Time : (10:30-12:00),
Effect of inhibitor binding on the 1H-15N HSQC spectra of RGS4.
SEMINAR 1. Title : Novel properties of graphene-based vertical-junction diodes and applications 2. Speaker : Suk-Ho Choi ( Dept. of Applied Physics,
Today’s Drug Discovery Process “How Do We Discover Drugs”
SEMINAR 1. Title : The Basics of OLED
SEMINAR 1. Title : Holotomography for non-invasive label-free 3-D imaging of live cells and tissues 2. Speaker : YongKeun Park ( KAIST ) 3.
RNAi Overview
SEMINAR 1. Title : Generation of Nucleic Acid Biopolymers with Complex Functionalities 2. Speaker : Prof. Seung Soo Oh (Department of Materials Sci. and.
SEMINAR 1. Title : Direct measurements of inter-membrane forces using Surface Forces Apparatus (SFA): Role of membrane protein concentrations and lipid.
SEMINAR 1. Title : Integration and characterization of long term stable novel graphene devices 2. Speaker : Byoung Hun Lee 3. Time : 16:00~17:00 4. Place.
SEMINAR 1. Title : Nanoscale Optical Spectroscopy
High Throughput Screening for Tuberculosis at NCL
SEMINAR 1. Title : Toward the first-principles design of next-generation electronic devices based on two-dimensional nanomaterials 2. Speaker : Yong-Hoon.
SEMINAR 1. Title : Introduction of Emotional Image Quality Metrology Technology 2. Speaker : Seungbae LEE, Master (Samsung Display) 3. Time : 15:00 – 18:00,
SEMINAR 1. Title : Roles of microRNA in immune cell biology
SEMINAR 1. Title: Thin Film Process Technology for AMOLED Display
SEMINAR 1. Title :Introduction of flow lithography and versatile applications 2. Speaker :Jiseok Lee 3. Time : 16:00~17:00 4. Place :: e+ Lecture Hall.
SEMINAR 1. Title : Growth, Fabrication, and Characterization of Nano-/Micro-structured LEDs 2. Speaker : Dong Seon Lee 3. Time : 16:00~17:00 4. Place ::
SEMINAR 1. Title : Imaging nanoscale magnetism with scanning magnetometers based on diamond quantum defects 2. Speaker : Donghun Lee.
ATOM Accelerating Therapeutics for Opportunities in Medicine
Membrane protein expression Proteins are the building blocks of all living organisms and play crucial roles in biological processes. To investigate how.
APPLICATIONS OF BIOINFORMATICS IN DRUG DISCOVERY
SEMINAR Title : Next Generation OLED
Discovery and Development of Medicines
An Introduction to Medicinal Chemistry 3/e
Ligand-Based Structural Hypotheses for Virtual Screening
Single chain antibody library Why single domain antibodies are preferred? Single domain antibodies represent the smallest antibody that was proven of diagnostic.
Proteolysis Targeting Chimera Profacgen. In mammalian cells, protein degradation is mainly carried out by the ubiquitin- proteasome system to dispose.
Drug Affinity Responsive Target Stability (DARTS).
Hydrophobic Tag Services Profacgen. Despite the great progress in developing ligands to specific proteins, there are only about 300 molecular targets.
Screening antibodies Creative Biolabs now offers high-throughput screening service of internalizing antibodies to our customers around the world. Integrated.
Gpcr antibody With rich experience in antibody discovery and membrane protein studies, experts from Creative Biolabs have launched a cutting-edge membrane.
Molecular Docking Profacgen. The interactions between proteins and other molecules play important roles in various biological processes, including gene.
Enzyme Annotation with Chemical Tools
Branko Stefanovic Biomedical Sciences
“Stem Cells and Cancer”
SEMINAR 1. Title : Quantum photonics with solid-state quantum emitters
Miquel Duran-Frigola, Roberto Mosca, Patrick Aloy  Chemistry & Biology 
Disruption of the interactions between the subunits of herpesvirus DNA polymerases as a novel antiviral strategy  A. Loregian, G. Palù  Clinical Microbiology.
How Chemoproteomics Can Enable Drug Discovery and Development
The Chemical Biology of Apoptosis
Pre – AP Biology Enzymes.
Paper Introduction By, Amrutha A.S..
Next Generation Sequencing Market. Report Description and Highlights According to Renub Research market research report “Next Generation Sequencing (NGS)
Presentation transcript:

SEMINAR 1. Title : Discovery of Protein-Protein Interaction Modulators Using Affinity-Based High-Throughput Screening 2. Speaker : Hyun-Suk Lim (포항공대 (POSTECH)) 3. Time : 16:00 – 17:00, Thursday, May 11, 2017 4. Place : e+ Lecture Hall (room 83188), 2nd Research Building, Sungkyunkwan University 5. Summary : The majority of drugs on the market today target proteins with well-defined small-molecule binding sites, including enzymes. However, some of the most devastating diseases are caused by proteins that do not possess these natural binding sites, such as those involved in protein-protein interactions associated with many cancers. Synthetic molecules capable of inhibiting disease-related protein-protein interactions are thus valuable research tools to investigate molecular functions of target proteins and further could be developed as novel therapeutic candidates. However, discovering such inhibitors is a daunting task due largely to the relatively large and flat protein interfaces involved in protein-protein interactions. In general, typical drug-like small molecules may not be suitable to effectively cover such extended protein contact areas. As such, there is an urgent need for the development of different types of molecules to target protein interfaces. In addition, the shortage of convenient high-throughput screening methods is another important reason that makes the identification of such inhibitors so challenging. Here I will present our development of novel chemical entities capable of mimicking protein surface structure and function as well as simple and efficient high-throughput screening strategies that enables to facilitate the discovery of chemical inhibitors of many disease-causing protein-protein interactions. 6 Background : Education 1987-1991 BS (Chemistry) Hanyang University 1991-1993 MS (Organic Chemistry) Hanyang University 2000-2004 PhD (Bioorganic Chemistry) POSTECH 2005-2008 Postdoctoral Fellow (Chemical Biology) University of Texas Southwestern Medical Center, USA Work 1993-2005 Principal Research Scientist, Choogwae Pharma. Corp. 2008-2012 Assistant Professor, Indiana University School of Medicine, USA 2012-present Associate Professor, POSTECH 7. Questions : (☏ 031-299-4115)